Skip to Content
<< Back
Quality Systems, Inc. Reports Fiscal 2017 Third Quarter Results
January 25, 2017 at 4:15 PM EST

IRVINE, Calif.--(BUSINESS WIRE)-- Quality Systems, Inc. (NASDAQ: QSII) announced today results for its fiscal 2017 third quarter ended December 31, 2016.

"We've seen a number of promising trends throughout the business this year, and I'm pleased with our fiscal third quarter results, as well as with the continued progress we're making on our strategic initiatives. In addition to improving our customer attrition rates, we've also made great strides in customer satisfaction over the last several quarters. During the first 75 days since our new software release, we've seen significant interest and already have nearly 500 customers signed up to upgrade," commented Rusty Frantz, president and chief executive officer of Quality Systems, Inc.

Mr. Frantz continued, "Through our restructuring, we've also identified meaningful RCM and EDI cross-selling opportunities within our existing customer base and hope to capitalize on them through the efforts of our newly reinvigorated salesforce. That said, given the uncertainty surrounding the ACA and the lengthy RCM sales cycle, we believe it will take some time before new bookings translate into top line growth. At this point in the year, I remain confident in delivering on the commitments we made in July."

Revenues for the fiscal 2017 third quarter of $127.9 million compared to $117.0 million a year ago. On a GAAP basis, net income for the 2017 third quarter was $10.5 million, compared with net income of $7.3 million in the 2016 third quarter. Non-GAAP net income for the 2017 third quarter was $14.4 million compared with non-GAAP net income of $10.0 million in the 2016 third quarter.

On a GAAP basis, fully diluted earnings per share was $0.17 in the fiscal 2017 third quarter compared with $0.12 earnings per share for the same period a year ago. On a non-GAAP basis, fully diluted earnings per share for the fiscal 2017 third quarter was $0.23 versus $0.16 reported in the third quarter a year ago.

Conference Call Information

Quality Systems will host a conference call to discuss its fiscal 2017 third quarter results on Wednesday, January 25, 2017 at 5:00 PM ET (2:00 PM PT). Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 866-900-9499 or 937-502-2136 for international callers, and referencing participant code 56791651 approximately 15 minutes prior to the call. A live webcast of the conference call will be available on the investor relations section of the company's web site and an audio file of the call will also be archived for 90 days at After the conference call, a replay will be available until February 1, 2017 and can be accessed by dialing 800-585-8367 or 404-537-3406 for international callers, and referencing participant code 56791651.

About Quality Systems, Inc.

Irvine, Calif.-based Quality Systems, Inc. (QSI) and its subsidiary, NextGen Healthcare Information Systems, develop and provide a range of software and services for medical and dental group practices, including practice management and electronic health record applications, patient portal, interoperability and connectivity products, and population health management and analytics offerings. Services include managed cloud services, revenue cycle management, claims clearinghouse, data interchange and value-add consulting. The Company's solution portfolio is readily integrated and collectively positioned to drive low total cost of ownership for its client partners, as well as enable the transition to value-based healthcare. Visit and for additional information.


This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements regarding future events, developments in the healthcare sector and regulatory framework, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue, net income, and earnings per share). Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements and additional risks and uncertainties are set forth in Part I, Item A of our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2016 and subsequently filed Quarterly Reports on Form 10-Q, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; disruptions caused by acquisitions of companies, products, or technologies; and general economic conditions. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of a fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.


This news release contains certain non-GAAP (Generally Accepted Accounting Principles) financial measures, which are provided only as supplemental information. Investors should consider these non-GAAP financial measures only in conjunction with the comparable GAAP financial measures. These non-GAAP measures are not in accordance with or a substitute for U.S. GAAP. Pursuant to the requirements of Regulation G, the Company has provided a reconciliation of non-GAAP financial measures to the most directly comparable financial measure in the accompanying financial tables. Other companies may calculate non-GAAP measures differently than Quality Systems, which limits comparability between companies. The Company believes that its presentation of non-GAAP diluted earnings per share provides useful supplemental information to investors and management regarding the Company's financial condition and results. The presentation of non-GAAP financial information is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP. The Company calculates non-GAAP diluted earnings per share by excluding net acquisition and disposition costs, amortization of acquired intangible assets, amortization of deferred debt issuance costs, loss on disposition, restructuring costs, net securities litigation defense costs, share-based compensation, and other non-run-rate expenses from GAAP income before provision for income taxes. The Company utilizes a normalized non-GAAP tax rate to provide better consistency across the interim reporting periods within a given fiscal year by eliminating the effects of non-recurring and period-specific items, which can vary in size and frequency, and which are not necessarily reflective of the Company's longer-term operations. The normalized non-GAAP tax rate applied to each quarter of fiscal year 2016 and expected to be applied for each quarter of fiscal year 2017 period is 30.5%. The determination of this rate is based on the consideration of both historic and projected financial results. The Company intends to re-evaluate this normalized non-GAAP tax rate on an annual basis or more frequently if any significant events occur that may materially affect this rate, such as merger and acquisition activity, changes in business outlook, or changes in expectations regarding tax regulations.

The Company's future period guidance in this release includes adjustments for items not indicative of the Company's core operations. Such adjustments are generally expected to be of a nature similar to those adjustments applied to the Company's historic GAAP financial results in the determination of the Company's non-GAAP diluted earnings per share. Such adjustments, however, may be affected by changes in ongoing assumptions and judgments as to the items that are excluded in the calculation of non-GAAP adjusted net income and adjusted diluted earnings per share, as described in this release. The exact amount and probable significance of these adjustments, including net acquisition and disposition costs, net securities litigation defense costs, and other non-run-rate expenses, are not currently determinable without unreasonable efforts, but may be significant. These items cannot be reliably quantified or forecasted due to the combination of their historic and expected variability. It is therefore not practicable to reconcile this non-GAAP guidance to the most comparable GAAP measures.

(In thousands, except per share data)
Three Months Ended December 31, Nine Months Ended December 31,
2016 2015 2016 2015
Software license and hardware $ 16,995 $ 16,150 $ 48,966 $ 52,026
Software related subscription services   22,546     11,705     63,911     36,388  
Total software, hardware and related 39,541 27,855 112,877 88,414
Support and maintenance 39,924 39,519 116,905 125,408
Revenue cycle management and related services 20,048 21,594 62,037 62,630
Electronic data interchange and data services 21,790 20,643 65,527 61,413
Professional services   6,565     7,421     19,893     26,700  
Total revenues   127,868     117,032     377,239     364,565  
Cost of revenue:
Software license and hardware 5,680 6,530 19,227 20,149
Software related subscription services   9,345     5,533     27,107     17,454  
Total software, hardware and related 15,025 12,063 46,334 37,603
Support and maintenance 7,299 7,537 20,903 23,874
Revenue cycle management and related services 13,462 14,381 42,052 43,573
Electronic data interchange and data services 12,662 12,437 38,232 37,302
Professional services   5,904     7,367     19,643     24,008  
Total cost of revenue   54,352     53,785     167,164     166,360  
Gross profit 73,516 63,247 210,075 198,205
Operating expenses:
Selling, general and administrative 37,542 39,395 120,913 115,962
Research and development costs, net 19,714 14,518 56,230 49,584
Amortization of acquired intangible assets 2,568 897 7,889 2,692
Restructuring costs   231     -     4,685     -  
Total operating expenses   60,055     54,810     189,717     168,238  
Income from operations 13,461 8,437 20,358 29,967
Interest income - 60 9 406
Interest expense   (629 )   (11 )   (2,445 )   (14 )
Other expense, net   (4 )   (43 )   (146 )   (147 )
Income before provision for income taxes 12,828 8,443 17,776 30,212
Provision for income taxes   2,342     1,141     3,950     8,233  
Net income $ 10,486   $ 7,302   $ 13,826   $ 21,979  
Net income per share:
Basic $ 0.17 $ 0.12 $ 0.22 $ 0.36
Diluted $ 0.17 $ 0.12 $ 0.22 $ 0.36
Weighted-average shares outstanding:
Basic 62,093 60,867 61,645 60,548
Diluted 62,093 61,279 61,900 61,190
Dividends declared per common share $ - $ 0.175 $ - $ 0.525
(In thousands, except per share data)
December 31, 2016 March 31, 2016
Current assets:
Cash and cash equivalents $ 23,994 $ 27,176
Restricted cash and cash equivalents 4,647 5,320
Marketable securities - 9,297
Accounts receivable, net 75,516 94,024
Inventory 252 555
Income taxes receivable 14,481 32,709
Prepaid expenses and other current assets   15,944     14,910  
Total current assets 134,834 183,991
Equipment and improvements, net 26,097 25,790
Capitalized software costs, net 12,995 13,250
Deferred income taxes, net 9,780 8,198
Intangibles, net 74,722 91,675
Goodwill 185,888 188,837
Other assets   18,703     19,049  
Total assets $ 463,019   $ 530,790  
Current liabilities:
Accounts payable 5,223 11,126
Deferred revenue 49,763 57,935
Accrued compensation and related benefits 18,620 18,670
Income taxes payable 8 91
Other current liabilities   44,338     50,238  

Total current liabilities

117,952 138,060
Deferred revenue, net of current 1,312 1,335
Deferred compensation 6,738 6,357
Line of credit 25,000 105,000
Other noncurrent liabilities   14,267     10,661  
Total liabilities 165,269 261,413
Commitments and contingencies
Shareholders' equity:
Common stock
$0.01 par value; authorized 100,000 shares; issued and outstanding 62,437 and 60,978 shares at December 31, 2016 and March 31, 2016, respectively 624 610
Additional paid-in capital 225,967 211,262
Accumulated other comprehensive loss (653 ) (481 )
Retained earnings   71,812     57,986  
Total shareholders' equity   297,750     269,377  
Total liabilities and shareholders' equity $ 463,019   $ 530,790  
(In thousands, except per share data)


Three Months Ended December 31, Nine Months Ended December 31,
2016 2015 2016 2015
Income before provision for income taxes - GAAP $ 12,828 $ 8,443 $ 17,776 $ 30,212
Non-GAAP adjustments:
Acquisition and disposition costs, net (1,337 ) 4,451 5,147 5,743
Amortization of acquired intangible assets 5,575 1,800 16,953 5,402
Amortization of deferred debt issuance costs 269 - 807 -
Loss on disposition of Hospital Solutions Division and related costs - 1,753 - 1,753
Restructuring costs 231 - 4,685 -
Securities litigation defense costs, net of insurance 356 (3,075 ) 1,483 (281 )
Share-based compensation 2,001 743 5,067 2,328
Other non-run-rate expenses*   739     335     2,865   1,722  
Total adjustments to GAAP income before provision for income taxes:   7,834     6,007     37,007   16,667  
Income before provision for income taxes - Non-GAAP 20,662 14,450 54,783 46,879
Provision for income taxes   6,302     4,407     16,709   14,298  
Net income - Non-GAAP $ 14,360   $ 10,043   $ 38,074 $ 32,581  
Diluted net income per share - Non-GAAP $ 0.23 $ 0.16 $ 0.62 $ 0.53
Weighted-average shares outstanding (diluted): 62,093 61,279 61,900 61,190
* For the three months ended December 31, 2016, other non-run-rate expenses consist primarily of professional services costs not related to core operations. Other non-run-rate expenses for the nine months ended December 31, 2016 consists primarily of professional services costs not related to core operations and $191 of executive hiring costs.
For the three months ended December 31, 2015, other non-run-rate expenses consists of non-recurring severance and other employee-related costs incurred in connection with the Hospital disposition. Other non-run-rate expenses for the nine months ended December 31, 2015 includes $449 in certain professional services costs not related to core operations, non-recurring severance and other employee-related costs incurred in connection with the Hospital disposition, and $938 of incremental costs related to the change in the Company's Chief Executive Officer, including recruitment fees and severance payments.

Quality Systems, Inc.
Jamie Arnold, Chief Financial Officer
Investor Contact:
Westwicke Partners
Bob East or Asher Dewhurst

Source: Quality Systems, Inc.

News Provided by Acquire Media